152 related articles for article (PubMed ID: 36403136)
21. Clinical features of isolated proximal-type immunoglobulin G4-related sclerosing cholangitis.
Takagi Y; Kubota K; Takayanagi T; Kurita Y; Ishii K; Hasegawa S; Iwasaki A; Sato T; Fujita Y; Kato S; Kagawa K; Watanabe S; Sekino Y; Hosono K; Matsuhashi N; Yamanaka S; Iwao T; Yoshida K; Nakajima A
Dig Endosc; 2019 Jul; 31(4):422-430. PubMed ID: 30570170
[TBL] [Abstract][Full Text] [Related]
22. Management, outcomes and survival of an Australian IgG4-SC cohort: The MOSAIC study.
Kemp W; Majeed A; Mitchell J; Majumdar A; Tse E; Skoien R; Croagh D; Dev A; Gao H; Weltman M; Craig P; Stuart K; Cheng W; Edmunds S; Lee E; Sood S; Metz A; Thompson A; Sinclair M; Beswick L; Nicoll A; Riordan S; Braund A; Muller K; MacQuillan G; Sandanayake N; Shackel N; Roberts SK
Liver Int; 2021 Dec; 41(12):2934-2943. PubMed ID: 34392596
[TBL] [Abstract][Full Text] [Related]
23. Relapse of IgG4-related sclerosing cholangitis after steroid therapy: image findings and risk factors.
You MW; Kim JH; Byun JH; Kim HJ; Lee SS; Kim MH; Lee MG
Eur Radiol; 2014 May; 24(5):1039-48. PubMed ID: 24573568
[TBL] [Abstract][Full Text] [Related]
24. IgG4 Sclerosing Cholangitis - an Inflammation Imitating Tumour of the Pancreas and Biliary Tract.
Peňázová P; Andrašina T; Novotný I; Trna J; Hemmelová B; Kunovsky L; Procházka V; Kala Z
Klin Onkol; 2019; 32(2):143-151. PubMed ID: 30995856
[TBL] [Abstract][Full Text] [Related]
25. Geoepidemiology of primary sclerosing cholangitis: a critical review.
Tanaka A; Takikawa H
J Autoimmun; 2013 Oct; 46():35-40. PubMed ID: 23932346
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulin G4-related sclerosing cholangitis.
Tanaka A
J Dig Dis; 2019 Jul; 20(7):357-362. PubMed ID: 31112324
[TBL] [Abstract][Full Text] [Related]
27. Epidemiological features of immunoglobulin G4-related sclerosing cholangitis in Japan.
Tanaka A; Mori M; Kubota K; Naitoh I; Nakazawa T; Takikawa H; Unno M; Kamisawa T; Kawa S; Okazaki K
J Hepatobiliary Pancreat Sci; 2020 Sep; 27(9):598-603. PubMed ID: 32603554
[TBL] [Abstract][Full Text] [Related]
28. The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis.
Itoi T; Kamisawa T; Igarashi Y; Kawakami H; Yasuda I; Itokawa F; Kishimoto Y; Kuwatani M; Doi S; Hara S; Moriyasu F; Baron TH
J Gastroenterol; 2013 Apr; 48(4):504-14. PubMed ID: 22948487
[TBL] [Abstract][Full Text] [Related]
29. Biliary and hepatic involvement in IgG4-related disease.
Joshi D; Webster GJ
Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1251-61. PubMed ID: 25312536
[TBL] [Abstract][Full Text] [Related]
30. Classification and Diagnostic Criteria for IgG4-Related Sclerosing Cholangitis.
Naitoh I; Nakazawa T
Gut Liver; 2022 Jan; 16(1):28-36. PubMed ID: 34380781
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of IgG4-related sclerosing cholangitis.
Nakazawa T; Naitoh I; Hayashi K; Miyabe K; Simizu S; Joh T
World J Gastroenterol; 2013 Nov; 19(43):7661-70. PubMed ID: 24282356
[TBL] [Abstract][Full Text] [Related]
32. Immunoglobulin G4-related sclerosing cholangitis.
Goodchild G; Pereira SP; Webster G
Korean J Intern Med; 2018 Sep; 33(5):841-850. PubMed ID: 30045615
[TBL] [Abstract][Full Text] [Related]
33. IgG4-Related Sclerosing Cholangitis.
Nakazawa T; Shimizu S; Naitoh I
Semin Liver Dis; 2016 Aug; 36(3):216-28. PubMed ID: 27466792
[TBL] [Abstract][Full Text] [Related]
34. Primary sclerosing cholangitis with elevated serum IgG4 levels and/or infiltration of abundant IgG4-positive plasma cells.
Koyabu M; Uchida K; Fukata N; Kusuda T; Ikeura T; Sakaguchi Y; Yoshida K; Shimatani M; Fukui T; Matsushita M; Uemura Y; Kaibori M; Takaoka M; Nishio A; Okazaki K
J Gastroenterol; 2010; 45(1):122-9. PubMed ID: 19760481
[TBL] [Abstract][Full Text] [Related]
35. New Thoughts on Immunoglobulin G4-Related Sclerosing Cholangitis.
Smit WL; Culver EL; Chapman RW
Clin Liver Dis; 2016 Feb; 20(1):47-65. PubMed ID: 26593290
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of laparoscopy and intraductal ultrasonography in a patient with isolated immunoglobulin G4-related sclerosing cholangitis.
Ohno Y; Kumagi T; Imamura Y; Kuroda T; Koizumi M; Watanabe T; Yoshida O; Tokumoto Y; Takeshita E; Abe M; Harada K; Hiasa Y
Clin J Gastroenterol; 2018 Feb; 11(1):62-68. PubMed ID: 29094322
[TBL] [Abstract][Full Text] [Related]
37. Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
Moon SH; Kim MH; Lee JK; Baek S; Woo YS; Cho DH; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol; 2017 Apr; 52(4):483-493. PubMed ID: 27470434
[TBL] [Abstract][Full Text] [Related]
38. A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
Radford-Smith DE; Selvaraj EA; Peters R; Orrell M; Bolon J; Anthony DC; Pavlides M; Lynch K; Geremia A; Bailey A; Culver EL; Probert F
Liver Int; 2022 Jun; 42(6):1344-1354. PubMed ID: 35129255
[TBL] [Abstract][Full Text] [Related]
39. Isolated intrapancreatic IgG4-related sclerosing cholangitis.
Nakazawa T; Ikeda Y; Kawaguchi Y; Kitagawa H; Takada H; Takeda Y; Makino I; Makino N; Naitoh I; Tanaka A
World J Gastroenterol; 2015 Jan; 21(4):1334-43. PubMed ID: 25632210
[TBL] [Abstract][Full Text] [Related]
40. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012.
Ohara H; Okazaki K; Tsubouchi H; Inui K; Kawa S; Kamisawa T; Tazuma S; Uchida K; Hirano K; Yoshida H; Nishino T; Ko SB; Mizuno N; Hamano H; Kanno A; Notohara K; Hasebe O; Nakazawa T; Nakanuma Y; Takikawa H; ; ; ;
J Hepatobiliary Pancreat Sci; 2012 Sep; 19(5):536-42. PubMed ID: 22717980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
